Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies
about
EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcriptionEpstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expressionMapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressorAbility of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cellsHuman Oncogenic Herpesvirus and Post-translational Modifications - Phosphorylation and SUMOylationSumoylated NHR-25/NR5A regulates cell fate during C. elegans vulval developmentZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virusMutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphomaCyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinasesThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1A unique SUMO-2-interacting motif within LANA is essential for KSHV latencyKaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivationGenome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodiesImplication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradationKaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivationArsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells.Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription.Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1Viral manipulation of the cellular sumoylation machinery.Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Computational identification of post-translational modification sites and functional families reveal possible moonlighting role of rotaviral proteinsThe Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsRegulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanismsSUMO: of branched proteins and nuclear bodies.DNA viruses and viral proteins that interact with PML nuclear bodies.Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein
P2860
Q24298061-04459419-E1D4-483A-A153-3C147A562315Q24317074-7D508E09-1574-4A93-9C92-11CAB6907067Q24336304-D9692833-FD3A-42AB-868C-1F4C3014DB5BQ24337028-568348EC-DBB0-47B1-AF94-42856F123092Q24528161-7DE6E9A1-6F8C-4C96-9C0B-33673383135EQ24529191-599E0E29-250F-40FF-9633-9B78131B8944Q24558692-9CF68DA1-4CCE-42DF-AD5E-27A2229B9D3EQ24563268-3111425F-8570-40A2-B16B-2908163A6A74Q26744568-A16FFB67-09C1-4015-A058-BC68F6CC8F84Q27318485-B749E654-5CF3-48BB-A937-6B4727173F5FQ28471803-9B33F103-012D-47CB-A599-58A998C66F6FQ28472086-130A8EEC-D11B-4BB8-A2CC-63FA1A01D5B4Q28475457-1C5B0188-228C-4C3A-BE69-CF034A2FA02BQ28480586-2A021298-5DB5-478F-A696-2372DAEFCD52Q28535343-4E72A9B8-0648-4D86-BAA6-8CBD89FC6BC8Q28535568-B9EB55F2-C3AE-43AE-B549-F0D7F603357AQ30845046-35B347B6-4799-403A-AD83-7AD78C0A10ACQ30860339-5AAAAF88-23F0-480B-8B3D-9A13B56AD0A4Q33321474-7578C89D-9E1A-47E3-B7FB-C2113998DAD3Q33575096-AB3D4A66-CBBB-4161-AB43-47EE5A2FB3EDQ33648307-2D561AE9-ECEE-49F8-BD13-D165CCA40874Q33716143-9DFA8EDD-94A7-421F-9ABD-F91F433927AEQ33823359-FB660BC5-5EE3-45B6-B25E-DC71C31D6857Q33826641-E632D6A4-2063-49AC-A248-C3A0561FD050Q33846061-945088EA-AF90-445B-A83F-7D9ACF1B9266Q33877497-F27E8E12-D8D8-42CA-9213-783834D8BE0CQ33908645-2EAEB266-2E7C-41AF-B104-44FC38BF8B92Q33908810-75D95A5E-1887-466B-B0D3-85506B9DF629Q33910635-867E2F52-2291-4335-B0C4-2BD513CD3105Q34120915-B059C7BC-B17B-4546-82C0-340EF3A30A8AQ34184000-236B5493-931F-4E37-815B-5B018EB61513Q34291099-EA47DD4F-2F51-4F08-B93C-5FBE4A2E9FEDQ34334212-E969AE3C-0E6E-468B-8EB4-27AF6A464FC8Q34350684-C8569BAE-744C-41D0-89E8-DFCB4DFEB94EQ34435551-3E547718-BE8D-4726-BD78-483D50F4D64BQ34435565-AAFA344F-E159-4A21-BC45-634383E2D23CQ34532370-C5701558-9060-4068-BDE1-2B8BBD4E35A7Q34553626-EDD662F0-114E-4340-816E-E6250015C0A7Q34576051-BC738478-D5D2-4F55-B20E-ABD29EAAB3D5Q34589844-357519BC-0742-4632-9807-B06DEBF3B290
P2860
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@ast
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en-gb
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@nl
type
label
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@ast
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en-gb
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@nl
prefLabel
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@ast
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en-gb
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@nl
P2860
P921
P3181
P1433
P1476
Epstein-barr virus immediate-e ...... promyelocytic leukemia bodies
@en
P2093
P2860
P304
P3181
P356
10.1128/JVI.75.5.2388-2399.2001
P407
P577
2001-03-01T00:00:00Z